The influence of voluntarily disclosed qualitative information

By V. Narayanan, G. E. Pinches, K. Kelm, Diane M. Lander. 2000

122 citations recorded by the source corpus.

Subfields: Accounting, Statistics and Probability, Strategy and Management

View Paper: https://www.semanticscholar.org/paper/c5eb29d1772a6f9159aaa1061c65957d12ee32ff

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Accounting

1. D. Gray
2. C. Baden-Fuller
3. Andy Neely
4. Aihua Wu
5. Maryann P. Feldman
6. Bernard Marr
7. P. Namara
8. Rolf Sternberg

In Statistics and Probability

1. Andy Neely
2. Maryann P. Feldman

In Strategy and Management

1. Bernard Marr
2. Andy Neely
3. D. Gray
4. C. Baden-Fuller
5. Aihua Wu
6. Maryann P. Feldman
7. M. Kelley
8. P. Namara

Citations in the corpus

• The ex ante assessment of knowledge spillovers: Government R&D policy, economic incentives and private firm behavior (2006, background): “The announcement of government funding itself may serve as an information signal to other investors (Lerner, 1999; Narayanan et al., 2000), particularly for small firms that would otherwise have difficulty attracting the attention of potential investors.”
• Why do firms measure their intellectual capital (2003, background): “In addition a number of empirical studies have also demonstrated that companies who are able to make meaningful disclosures about their long-term prospects achieve more satisfactory market valuations ( Narayanan et al , 2000”
• Corporate Reporting of Nonfinancial Leading Indicators of Economic Performance and Sustainability (2012, unknown): “Disclosure of non-financial information is essential to reduce the information asymmetry that exists between management and important stakeholders (Narayanan et al. 2000).”
• The signal effect of Government R&D Subsidies in China: Does ownership matter? (2017, background): “Narayanan et al. (2000) argue that actions related to governmental agencies, like approving new products, granting patents or awarding subsidies, may serve as an information signal to other investors.”
• Shareholder returns and the exploration–exploitation dilemma: R&D announcements by biotechnology firms (2007, background): “, 1986) and disclosure of on-going projects, such as R&D (Narayanan et al., 2000), new product launches (Chaney et al.”